跳至主要内容
临床试验/NCT06636825
NCT06636825已完成不适用

Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia

United States Army Research Institute of Environmental Medicine1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2023年11月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
29
试验地点
1
主要终点
End-tidal CO2

研究概览

简要总结

The aim of this randomized, double-blind, placebo-controlled crossover trial is to determine the effects of caffeine vs. placebo on psychomotor vigilance and carbon dioxide tolerance during graded hypercapnia.

详细描述

Healthy and fit young adults (men and women) will participate in this study. Participants will perform two primary experimental trials on separate days, one after consuming 400 mg caffeine, and the other after consuming a non-caffeinated placebo. During each trial, participants will breathe increasing levels of inspired CO2 in a stepwise manner (0%, 2%, 4%, 6%, 8% CO2; all with 21% oxygen) during successive 12-minute stages. The endpoints of the graded hypercapnia protocol will be completion of the 8% CO2 stage, voluntary subject termination due to discomfort, or end-tidal CO2 greater than 70 mmHg. The investigators hypothesize that, compared to placebo, caffeine will lower end tidal and arterialized PCO2 and mitigate CO2-mediated decrements in psychomotor vigilance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, age 18-45
  • Body mass index 18.5-30.0 kg m-2
  • Body mass 50-100 kg
  • In good health as determined by the Office of Medical Support & Oversight (OMSO) General Medical Clearance
  • Perform exercise at least 2 times per week
  • Willing to abstain from exercise and alcoholic beverages for 24 hours before each study visit.
  • Willing to abstain from caffeine for 12 hours prior to all study visits
  • Willing to abstain from caffeine for 12 hours after visits 3 and 4
  • Willing to remain fasted (no food or fluid other than water) from lights out until after arrival at the laboratory the following morning on each study day (~10 hours)
  • Have supervisor approval if permanent party military or a federal employee at U.S. Army Natick Soldier System Center

排除标准

  • Females who are pregnant or planning to become pregnant during the study
  • Females who are surgically sterile
  • History of severe adverse reaction to caffeine (e.g., headache, dizziness, diarrhea, insomnia)
  • Taking dietary supplements, prescriptions, or over the counter medication, other than a contraceptive (unless approved by OMSO & PI)
  • Abnormal blood count (For example: hemoglobin (Hb) outside of the typical normal values reported by LabCorp in accordance with OMSO (Normal [Hb] Males = 12.6-17.7 g/dL; Females = 11.1-15.9 g/dL) or hematocrit (Hct) outside of the normal ranges (Normal Hct Males = 37.5-51.0%; Females = 34.0-46.6%) levels, presence of abnormal blood chemicals (hemoglobin S or sickle cell traits)
  • Any history of pulmonary or cardiovascular disease
  • Current diagnosis of asthma (childhood asthma with no recurrence in the last 5 years ok)
  • Smokers or nicotine users (unless have quit >1 month prior)
  • Current or recent respiratory tract or sinus infections (< 1 month prior)
  • Current diagnosis of migraine or recurrent headaches (previous diagnosis with no recurrence in the last 5 years ok)
  • Any history of seizures
  • Any history of panic disorder
  • Blood donation in the previous 8 weeks
  • Positive Covid-19 test within the last month (based on self-report)

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo (microcrystalline cellulose) capsule taken in a single dose 1 hour prior to graded hypercapnia

干预措施: Graded hypercapnia (Other)

Placebo

Placebo Comparator

Placebo (microcrystalline cellulose) capsule taken in a single dose 1 hour prior to graded hypercapnia

干预措施: Placebo (Drug)

Experimental

Experimental

400 mg caffeine capsule taken in a single dose 1 hour prior to graded hypercapnia

干预措施: Graded hypercapnia (Other)

Experimental

Experimental

400 mg caffeine capsule taken in a single dose 1 hour prior to graded hypercapnia

干预措施: Caffeine (Drug)

结局指标

主要结局

End-tidal CO2

时间窗: 60 minutes

End-tidal CO2 (mmHg)

PVT Performance

时间窗: 60 minutes

Psychomotor vigilance (mean reaction time in s)

Carbon dioxide tolerance

时间窗: 60 minutes

Time spent in graded hypercapnia protocol (minutes)

次要结局

  • Ventilation(60 minutes)
  • Respiratory Rate(60 minutes)
  • Tidal volume(60 minutes)
  • Oxygen Consumption(60 minutes)
  • Carbon dioxide release(60 minutes)
  • Heart Rate(60 minutes)
  • Blood Pressure(60 minutes)
  • Total Mood Disturbance(60 minutes)
  • Arterialized capillary pH(60 minutes)
  • Arterialized capillary PCO2(60 minutes)
  • Arterialized capillary bicarbonate(60 minutes)
  • Dyspnea(60 minutes)
  • Discomfort(60 minutes)
  • Headache(60 minutes)
  • Plasma caffeine(60 minutes)
  • Plasma theobromine(60 minutes)
  • Plasma theophylline(60 minutes)
  • Plasma paraxanthine(60 minutes)

研究者

发起方
United States Army Research Institute of Environmental Medicine
申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Influence of Caffeine on Psychomotor Vigilance and... | 临床试验